Flagship record · Carbetocin

Uterotonics update.

reviewnarrative reviewcontextual mention

Scientific attribution

The source provides review, development, protocol, or other contextual evidence rather than a peptide-specific primary intervention.

PMID: 39764811
DOI: 10.1016/j.bpa.2024.10.007
Sample size: Not captured in the structured review record
Population / model: Choice of second-line uterotonic will vary depending on the comorbidities of the patient.

Key findings

First-line uterotonics comprise oxytocin and carbetocin, which act on the oxytocin receptor, and recent research has shown that lower doses of first-line uterotonics can be used to adequate effect.

Review status

This research library contains structured AI-assisted scientific review. AI-assisted review is not accountable human scientific approval. Inclusion here does not constitute publication approval, clinical guidance, efficacy proof, or automatic promotion of a scientific conclusion.

Loading research intelligence

Preparing the structured Flagship evidence library.